Literature DB >> 10213122

Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan.

K Omagari1, H Kinoshita, Y Kato, K Nakata, T Kanematsu, Y Kusumoto, I Mori, R Furukawa, H Tanioka, H Tajima, M Koga, M Yano, S Kohno.   

Abstract

We examined the clinical characteristics of 89 patients with autoimmune hepatitis (AIH) in Nagasaki Prefecture, Japan, and assessed the usefulness of a provisional scoring system for the diagnosis of AIH proposed by the International Autoimmune Hepatitis Group in 1993. The majority of patients were middle-aged women in their fifties. All patients showed a hepatitic picture. Forty-three patients (48%) had an insidious or chronic onset, while 34 (38%) had an acute onset, and 12 (14%) had liver cirrhosis at presentation. Seventy-nine patients (89%) were positive for antinuclear antibody (ANA), and 5 (6%) were positive for antibody to the hepatitis C virus (anti-HCV). The prognosis was good, with 90% 3-year survival, and most patients responded well to treatment with corticosteroids. The international scoring system was useful for the diagnosis of AIH in most of our patients; the percentages of patients with definite and probable AIH were 48% and 47%, respectively. However, certain factors, such as negative ANA, positive antimitochondrial antibody, concurrent infection with hepatitis B or C virus, and insufficient response to treatment precluded the diagnosis of AIH in some patients. Whether these patients were indeed "true" AIH patients is not clear at present, and further investigation of such patients may be useful for a better understanding of AIH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213122     DOI: 10.1007/s005350050247

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  9 in total

1.  Primary sclerosing cholangitis associated with lupus nephritis: a rare association.

Authors:  Yoshiko Kadokawa; Katsuhisa Omagari; Isao Matsuo; Yoshiko Otsu; Umpei Yamamoto; Tomoya Nishino; Kazuo Ohba; Masanobu Miyazaki; Takashi Harada; Takashi Taguchi; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  Relationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese.

Authors:  X Ma; D K Qiu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Role of international criteria in the diagnosis of autoimmune hepatitis.

Authors:  Mohammad Reza Abdollahi; Mohammad Hossein Somi; Esmaeil Faraji
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

4.  Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group.

Authors:  Lok-Beng Koay; Ching-Yih Lin; Sun-Lung Tsai; Chuan Lee; Ching-Nan Lin; Ming-Juen Sheu; Hsing-Tao Kuo; Chi-Shu Sun
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

5.  Clinical features and long term outcome of 102 treated autoimmune hepatitis patients.

Authors:  Zinab Malekzadeh; Sepideh Haghazali; Sadaf G Sepanlou; Homayoon Vahedi; Shahin Merat; Masoud Sotoudeh; Siavosh Nasseri-Moghaddam; Reza Malekzadeh
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

6.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

Review 7.  Autoimmune hepatitis: current challenges and future prospects.

Authors:  Yoshio Aizawa; Atsushi Hokari
Journal:  Clin Exp Gastroenterol       Date:  2017-01-19

8.  Long-term treatment outcomes for autoimmune hepatitis in Korea.

Authors:  Jae Sook Kil; Joon Hyoek Lee; A-Reum Han; Ja Young Kang; Hye Jin Won; Han Young Jung; Hyun Min Lim; Geum-Youn Gwak; Moon Seok Choi; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  J Korean Med Sci       Date:  2009-12-29       Impact factor: 2.153

9.  Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report.

Authors:  Giovanni Covini; Elena Bredi; Salvatore Badalamenti; Massimo Roncalli; Alessio Aghemo; Massimo Colombo
Journal:  Hepatol Commun       Date:  2018-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.